A unique feature of these peptides was that they were internalised by breast and prostate cancer cells, suggestive of an inherent ability of these peptides to possibly interfere with RHAMM’s intracellular functions, although this requires experimental substantiation (129). Here, HMMR is linked to prostate cancer.